Related Experiment Video
Updated: Mar 11, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions
Suzanne M Eken1, Hong Jin1, Ekaterina Chernogubova1
1From the Department of Medicine (S.M.E., H.J., E.C., Y.L., N.S., C.S., G.K., A.B., A.B., P.E., M.G.D., G.K.H., G.P.-B., L.M.) and Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden (G.K., C.Ö., A.R., T.R., L.P.M., U.H.); Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL (C.Ö.); Institute for Clinical Chemistry and Laboratory Medicine, University Medical Centre Hamburg-Eppendorf, Germany (T.R.); Department of Vascular and Endovascular Surgery, Technical University Munich and DZHK Partner Site Munich, Germany (H.H.E., J.P., L.M.); Heart Center, Georg-August-University Göttingen, Germany (I.N.S., U.R.); and Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA (N.J.L.).
Low miR-210 expression characterizes unstable carotid plaques linked to stroke risk. Restoring miR-210 stabilizes plaques by targeting APC, offering a potential therapy for vascular disease.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genomics
Background:
- MicroRNAs (miRNAs) are key regulators in vascular disease.
- Identifying specific miRNAs can reveal therapeutic targets for cardiovascular conditions.
Purpose of the Study:
- Investigate microRNAs in patients with unstable carotid stenosis.
- Determine the role of specific miRNAs in stroke risk associated with carotid plaques.
Main Methods:
- miRNA expression profiling using PCR-based arrays on plasma from carotid lesion sites.
- Laser capture microdissection and in situ hybridization for miRNA localization.
- In vitro and in vivo studies in rodent models to assess miR-210 function.
Main Results:
- Eight miRNAs were deregulated in unstable carotid plaques, with miR-210 being significantly downregulated.
- miR-210 was localized to fibrous caps and directly targets the APC gene, influencing Wnt signaling and smooth muscle cell survival.
- Modulating miR-210 improved fibrous cap stability in preclinical models.
Conclusions:
- Low miR-210 expression is a marker of unstable carotid plaques and stroke risk.
- miR-210 promotes plaque stability by inhibiting APC and supporting smooth muscle cell survival.
- Local delivery of miR-210 presents a novel therapeutic strategy for preventing atherothrombotic events.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

